Epidemiology and semeiotics of endocrine diseases

Epidemiology and semeiotics of endocrine diseases 


The Burden of Hormonal Disorders: A Worldwide Overview With a Particular Look in Italy (adapted from Front Endocrinol 2021)
Andrea Crafa, Aldo E. Calogero1, Rossella Cannarella, Laura M. Mongioì, Rosita A. Condorelli, Emanuela A. Greco, Antonio Aversa and Sandro La Vignera

Endocrine diseases have a considerable impact on public health from an epidemiological point of view and because they may cause long-term disability, alteration of the quality-of-life of the affected patients, and are the fifth leading cause of death. In this extensive review of the literature, we have evaluated the prevalence of the different disorders of endocrine interest in the world and Italy, highlighting their epidemiological, clinical, and economic impact.


Physical examination for endocrinological diseases: does it still play a role? (adapted from J Clin Med 2022)
Andrea Crafa, Rosita A. Condorelli, Rossella Cannarella, Antonio Aversa, Aldo E. Calogero and Sandro La Vignera

A physical examination represents a fundamental step in diagnosing diseases. Due to the role that hormones play in the regulation of numerous biological processes in various organs and systems, endocrine diseases cause a variety of clinical manifestations that can be easily identified with a careful physical examination and can guide the clinician to specific diagnoses. Furthermore, the presence of specific clinical signs in various endocrine‐metabolic diseases can predict the risk of developing comorbidities and serious adverse events. In this article, we present some of the main clinical signs of endocrine‐metabolic diseases and the risk of comorbidities, summarizing the pathogenetic mechanisms that lead to their formation. The aim is to highlight how the identification of these specific signs can reduce the number of dynamic tests and the costs necessary to reach the diagnosis and allow the early identification of any complications associated with these diseases, improving the clinical management of affected patients.


Authors:

Sandro La Vignera, Professor of Endocrinology, University of Catania, Catania, Italy
Antonio Aversa, Professor of Endocrinology, University of Catanzaro, Catanzaro, Italy
Aldo E. Calogero, Professor of Endocrinology, University of Catania, Catania, Italy

Collaborators (alphabetical order):
Rossella Cannarella, Endocrinologist, University of Catania, Catania, Italy
Rosita A. Condorelli, Professor of Endocrinology, University of Catania, Catania, Italy
Andrea Crafa, Graduate School of Endocrinology, University of Catania, Catania, Italy
Emanuela A. Greco, Professor of Endocrinogy, University UNICUSANO, Rome, Italy
Laura M. Mongioì, Endocrinologist, University of Catania, Catania, Italy

Ansia da prestazione o vera disfunzione erettile ? Studio dell’Università di Catania, pubblicato su Journal of Clinical Medicine

Quante volte ci siamo chiesti, in particolare gli uomini che ne so!rono e le rispettive compagne, se si trattasse di un vero disturbo di erezione o semplicemente di una questione di ansia da prestazione ?

Adesso uno studio clinico dal titolo “Differences in Penile Hemodynamic Profiles in Patients with Erectile Dysfunction and Anxiety” pubblicato sulla prestigiosa rivista internazionale Journal of Clinical Medicine, ad opera degli endocrinologi del Policlinico Universitario di Catania in collaborazione con i colleghi dell’Università di Catanzaro, suggerisce un originale algoritmo diagnostico in grado di facilitare la comprensione di questa difficile diagnosi differenziale, che comporta nei fatti, strategie terapeutiche completamente differenti.

Ci siamo basati sull’analisi velocitometrica delle arterie cavernose dopo stimolo farmacologico – spiegano Aldo Calogero e Sandro La Vignera -, l’erezione è un fenomeno neuro-endocrino-vascolare inducibile mediante...

Articolo completo su:

La Sicilia

Lasiciliaweb.it

Qds.it

Cataniatoday.it

Liveuniversity.it

SiciliaReport.it

Diabete mellito: la cura farmacologica migliora la funzione testicolare

Diabete mellito, cura farmacologica migliora la funzione testicolare

I farmaci ipoglicemizzanti di nuova generazione, impiegati nella cura farmacologica del diabete mellito migliorerebbero la funzione testicolare. Lo rivela un recente editoriale – dal titolo “Is there a role for glucagon-like peptide-1 receptor agonists in the treatment of male infertility?”- pubblicato sulla rivista Internazionale “Andrology”, organo ufficiale di European Academy of Andrology, a firma dei docenti e ricercatori endocrinologi Sandro La Vignera, Rosita Angela Condorelli, Rossella Cannarella e Aldo Eugenio Calogero del Policlinico “Rodolico” dell’Università di Catania in collaborazione con il prof. Antonio Aversa ed Emanuela Greco dell’Università di Catanzaro.